• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期感染可预测季节性甲型流感病例的年龄分布。

Earliest infections predict the age distribution of seasonal influenza A cases.

机构信息

Department of Ecology and Evolutionary Biology, University of Chicago, Chicago, United States.

Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, United States.

出版信息

Elife. 2020 Jul 7;9:e50060. doi: 10.7554/eLife.50060.

DOI:10.7554/eLife.50060
PMID:32633233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7367686/
Abstract

Seasonal variation in the age distribution of influenza A cases suggests that factors other than age shape susceptibility to medically attended infection. We ask whether these differences can be partly explained by protection conferred by childhood influenza infection, which has lasting impacts on immune responses to influenza and protection against new influenza A subtypes (phenomena known as original antigenic sin and immune imprinting). Fitting a statistical model to data from studies of influenza vaccine effectiveness (VE), we find that primary infection appears to reduce the risk of medically attended infection with that subtype throughout life. This effect is stronger for H1N1 compared to H3N2. Additionally, we find evidence that VE varies with both age and birth year, suggesting that VE is sensitive to early exposures. Our findings may improve estimates of age-specific risk and VE in similarly vaccinated populations and thus improve forecasting and vaccination strategies to combat seasonal influenza.

摘要

季节性流感病例年龄分布的变化表明,除年龄因素外,还有其他因素影响着有医疗记录的感染易感性。我们想知道,这些差异是否可以部分归因于儿童期流感感染所带来的保护,这种保护对流感的免疫反应和预防新的甲型流感亚型(被称为原始抗原性和免疫印记的现象)产生持久影响。通过对流感疫苗有效性(VE)研究数据拟合统计模型,我们发现原发性感染似乎会降低一生中该亚型有医疗记录感染的风险。与 H3N2 相比,这种影响在 H1N1 中更强。此外,我们还发现 VE 随年龄和出生年份而变化的证据,这表明 VE 对早期暴露敏感。我们的研究结果可能会改进类似接种人群中特定年龄风险和 VE 的估计,从而改善季节性流感的预测和疫苗接种策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/b4362a010a8b/elife-50060-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/6576b3866135/elife-50060-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/a324b8511d47/elife-50060-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/0c95a7799d6a/elife-50060-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/f7910bad8214/elife-50060-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/724ec0940ef3/elife-50060-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/ad2e8718c4ec/elife-50060-fig1-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/6b4123b2f631/elife-50060-fig1-figsupp6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/4108065a7c09/elife-50060-fig1-figsupp7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/08154c452125/elife-50060-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/3fde419f901c/elife-50060-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/5d45c4840858/elife-50060-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/316fe3d301d9/elife-50060-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/20ec55238e5a/elife-50060-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/98451a78ce6e/elife-50060-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/1e8a1f2159c2/elife-50060-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/636e5489427a/elife-50060-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/683da21db5bf/elife-50060-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/5566cd2d859b/elife-50060-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/948b0061c3f0/elife-50060-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/fd8f72025ece/elife-50060-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/f8c2bf75d574/elife-50060-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/32611520120f/elife-50060-fig5-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/40946d7b0e58/elife-50060-fig5-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/66ce75780a79/elife-50060-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/bfa18b880068/elife-50060-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/c41209db0994/elife-50060-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/b4362a010a8b/elife-50060-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/6576b3866135/elife-50060-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/a324b8511d47/elife-50060-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/0c95a7799d6a/elife-50060-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/f7910bad8214/elife-50060-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/724ec0940ef3/elife-50060-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/ad2e8718c4ec/elife-50060-fig1-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/6b4123b2f631/elife-50060-fig1-figsupp6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/4108065a7c09/elife-50060-fig1-figsupp7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/08154c452125/elife-50060-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/3fde419f901c/elife-50060-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/5d45c4840858/elife-50060-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/316fe3d301d9/elife-50060-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/20ec55238e5a/elife-50060-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/98451a78ce6e/elife-50060-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/1e8a1f2159c2/elife-50060-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/636e5489427a/elife-50060-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/683da21db5bf/elife-50060-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/5566cd2d859b/elife-50060-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/948b0061c3f0/elife-50060-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/fd8f72025ece/elife-50060-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/f8c2bf75d574/elife-50060-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/32611520120f/elife-50060-fig5-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/40946d7b0e58/elife-50060-fig5-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/66ce75780a79/elife-50060-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/bfa18b880068/elife-50060-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/c41209db0994/elife-50060-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd4/7367686/b4362a010a8b/elife-50060-fig7.jpg

相似文献

1
Earliest infections predict the age distribution of seasonal influenza A cases.早期感染可预测季节性甲型流感病例的年龄分布。
Elife. 2020 Jul 7;9:e50060. doi: 10.7554/eLife.50060.
2
Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.2003 - 2011年西班牙利用监测数据开展的检测阴性病例对照研究:与甲型H3N2流感季节相比,季节性甲型H1N1流感为主导流行的季节中疫苗有效性更高
Vaccine. 2014 Jul 31;32(35):4404-4411. doi: 10.1016/j.vaccine.2014.06.063. Epub 2014 Jun 23.
3
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.在一个同时流行三种流感病毒型/亚型的季节里,对欧洲流感疫苗有效性的评估:I-MOVE 多中心病例对照研究,2012/13 年流感季节。
Euro Surveill. 2014 Feb 13;19(6):20701. doi: 10.2807/1560-7917.es2014.19.6.20701.
4
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.2014/15 年在欧洲,I-MOVE 多中心病例对照研究中,在甲型 H1N1pdm09、乙型和漂移型甲型 H3N2 流感共同流行的季节,初级保健患者中预防实验室确诊流感的疫苗效力。
Euro Surveill. 2016;21(7):pii=30139. doi: 10.2807/1560-7917.ES.2016.21.7.30139.
5
Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.在初级保健中,流感疫苗预防有医疗记录的流感病毒感染的效果,以色列,2014/15 年和 2015/16 年流感季节。
Euro Surveill. 2018 Feb;23(7). doi: 10.2807/1560-7917.ES.2018.23.7.17-00026.
6
Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.希腊六季(2013-2014 至 2018-2019 年)流感疫苗对住院确诊流感的有效性:一项汇总分析。
Vaccine. 2020 Mar 10;38(12):2715-2724. doi: 10.1016/j.vaccine.2020.01.083. Epub 2020 Feb 6.
7
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.超越抗原匹配:2015-2016 年加拿大流感季节疫苗效力的可能宿主和免疫流行病学影响因素。
J Infect Dis. 2017 Dec 19;216(12):1487-1500. doi: 10.1093/infdis/jix526.
8
Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.季节性流感疫苗对实验室确诊流感住院的效果-拉丁美洲,2013 年。
Vaccine. 2018 Jun 7;36(24):3555-3566. doi: 10.1016/j.vaccine.2017.06.036. Epub 2017 Jun 23.
9
Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15.季节性流感疫苗有效性的实时真实世界分析:瑞典斯德哥尔摩郡基于人群队列的方法开发与评估,2011/12至2014/15季节
Euro Surveill. 2016 Oct 27;21(43). doi: 10.2807/1560-7917.ES.2016.21.43.30381.
10
Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.2014-2015 年季节希腊通过实验室确诊流感住院的流感疫苗效果:一项病例对照研究。
J Med Virol. 2016 Nov;88(11):1896-904. doi: 10.1002/jmv.24551. Epub 2016 Apr 26.

引用本文的文献

1
Induction of hemagglutinin stalk reactive antibodies by the administration of a live-attenuated influenza virus vaccine in children.在儿童中接种减毒活流感病毒疫苗诱导血凝素茎部反应性抗体。
iScience. 2025 Jun 13;28(7):112893. doi: 10.1016/j.isci.2025.112893. eCollection 2025 Jul 18.
2
Future disease burden due to the rise of emerging infectious disease secondary to climate change may be being under-estimated.气候变化导致的新发传染病增加所带来的未来疾病负担可能被低估了。
Virulence. 2025 Dec;16(1):2501243. doi: 10.1080/21505594.2025.2501243. Epub 2025 May 11.
3
High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains.

本文引用的文献

1
Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics.儿童时期对甲型流感的免疫印记塑造了季节性 H1N1 和 H3N2 流行期间与出生年份相关的风险。
PLoS Pathog. 2019 Dec 19;15(12):e1008109. doi: 10.1371/journal.ppat.1008109. eCollection 2019 Dec.
2
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin.绘制针对流感血凝素的多克隆血清靶向逃逸的病毒突变的个体间变异图谱。
Elife. 2019 Aug 27;8:e49324. doi: 10.7554/eLife.49324.
3
Birth Cohort Effects in Influenza Surveillance Data: Evidence That First Influenza Infection Affects Later Influenza-Associated Illness.
高通量中和测量与人类流感毒株的进化成功密切相关。
bioRxiv. 2025 Mar 12:2025.03.04.641544. doi: 10.1101/2025.03.04.641544.
4
Estimating Standard-Dose and High-Dose Fluzone Vaccine Efficacies for Influenza A Based on Hemagglutination Inhibition Titers.基于血凝抑制效价估算甲型流感标准剂量和高剂量流感裂解疫苗的效力
J Infect Dis. 2025 Jun 2;231(5):1336-1345. doi: 10.1093/infdis/jiae615.
5
Reconstructed influenza A/H3N2 infection histories reveal variation in incidence and antibody dynamics over the life course.重建的甲型流感 H3N2 感染史揭示了一生中发病率和抗体动态的变化。
PLoS Biol. 2024 Nov 7;22(11):e3002864. doi: 10.1371/journal.pbio.3002864. eCollection 2024 Nov.
6
Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017-2018 Season and Reveal Age-Associated Differences in Susceptibility and Antibody-Binding Specificity.人群免疫水平可预测 2017-2018 年季节甲型流感(H3N2)的优势株,并揭示年龄相关的易感性和抗体结合特异性差异。
Influenza Other Respir Viruses. 2024 Nov;18(11):e70033. doi: 10.1111/irv.70033.
7
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1.人类和仓鼠血清在鉴定 SARS-CoV-2 变体(包括 JN.1)中的抗原漂移方面具有良好的相关性。
J Virol. 2024 Nov 19;98(11):e0094824. doi: 10.1128/jvi.00948-24. Epub 2024 Oct 4.
8
Influenza virus antibodies inhibit antigen-specific B cell responses in mice.流感病毒抗体可抑制小鼠的抗原特异性 B 细胞反应。
J Virol. 2024 Sep 17;98(9):e0076624. doi: 10.1128/jvi.00766-24. Epub 2024 Aug 28.
9
Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin.流感血凝素突变的抗原效应在年龄依赖性方面存在异质性。
Cell Host Microbe. 2024 Aug 14;32(8):1397-1411.e11. doi: 10.1016/j.chom.2024.06.015. Epub 2024 Jul 19.
10
Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin.生命早期的免疫印迹塑造了对乙型流感病毒血凝素的交叉反应性。
Nat Microbiol. 2024 Aug;9(8):2073-2083. doi: 10.1038/s41564-024-01732-8. Epub 2024 Jun 18.
出生队列效应对流感监测数据的影响:首次流感感染影响后续流感相关疾病的证据。
J Infect Dis. 2019 Jul 31;220(5):820-829. doi: 10.1093/infdis/jiz201.
4
Age-specific differences in the dynamics of protective immunity to influenza.流感保护性免疫的动态在年龄特异性方面的差异。
Nat Commun. 2019 Apr 10;10(1):1660. doi: 10.1038/s41467-019-09652-6.
5
Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.既往接种史与儿童接种活疫苗或灭活疫苗的流感疫苗效力的相关性。
JAMA Netw Open. 2018 Oct 5;1(6):e183742. doi: 10.1001/jamanetworkopen.2018.3742.
6
Reporting and evaluating influenza virus surveillance data: An argument for incidence by single year of age.报告和评估流感病毒监测数据:按单一年龄组发病率进行分析的观点
Vaccine. 2018 Oct 8;36(42):6249-6252. doi: 10.1016/j.vaccine.2018.08.077. Epub 2018 Sep 12.
7
Measurement of Vaccine Direct Effects Under the Test-Negative Design.在阴性检测设计下测量疫苗的直接效果。
Am J Epidemiol. 2018 Dec 1;187(12):2686-2697. doi: 10.1093/aje/kwy163.
8
Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations .具有 narrowly focused 流感病毒抗体的个体血清可快速选择病毒逃逸突变。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00859-18. Print 2018 Oct 1.
9
Risk Factors and Attack Rates of Seasonal Influenza Infection: Results of the Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) Seroepidemiologic Cohort Study.季节性流感感染的危险因素和发病率:南半球流感和疫苗有效性研究与监测(SHIVERS)血清流行病学队列研究结果。
J Infect Dis. 2019 Jan 9;219(3):347-357. doi: 10.1093/infdis/jiy443.
10
Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014.利用 1999-2014 年 29 个国家基于病例的全球监测数据按年龄分布的流感病毒类型。
BMC Infect Dis. 2018 Jun 8;18(1):269. doi: 10.1186/s12879-018-3181-y.